IBDEI07B ; ; 09-FEB-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4)
 ;;=^IBE(358.4,
 ;;^UTILITY(U,$J,358.4,0)
 ;;=IMP/EXP SELECTION GROUP^358.4I^654^654
 ;;^UTILITY(U,$J,358.4,1,0)
 ;;=INPT H&P-NEW ADMISSION^4^1
 ;;^UTILITY(U,$J,358.4,2,0)
 ;;=INITIAL OBSERVATION^1^1
 ;;^UTILITY(U,$J,358.4,3,0)
 ;;=INPT CONSULTATIONS^5^1
 ;;^UTILITY(U,$J,358.4,4,0)
 ;;=INPT-ESTABLISHED PATIENT CARE^6^1
 ;;^UTILITY(U,$J,358.4,5,0)
 ;;=INPT DISCHARGES^7^1
 ;;^UTILITY(U,$J,358.4,6,0)
 ;;=SUBSEQUENT OBSERVATION^2^1
 ;;^UTILITY(U,$J,358.4,7,0)
 ;;=OBSERVATION DISCHARGE^3^1
 ;;^UTILITY(U,$J,358.4,8,0)
 ;;=INJECTIONS/DRUGS^4^2
 ;;^UTILITY(U,$J,358.4,9,0)
 ;;=WOUND CARE^7^2
 ;;^UTILITY(U,$J,358.4,10,0)
 ;;=MD PROCEDURES^1^2
 ;;^UTILITY(U,$J,358.4,11,0)
 ;;=MUSCLE NERVE TESTS^5^2
 ;;^UTILITY(U,$J,358.4,12,0)
 ;;=TEAM CONFERENCE^6^2
 ;;^UTILITY(U,$J,358.4,13,0)
 ;;=ACUPUNCTURE^2^2
 ;;^UTILITY(U,$J,358.4,14,0)
 ;;=CHEMODENERVATION^3^2
 ;;^UTILITY(U,$J,358.4,15,0)
 ;;=V CODES ^19^3
 ;;^UTILITY(U,$J,358.4,16,0)
 ;;=AMPUTATION STATUS^3^3
 ;;^UTILITY(U,$J,358.4,17,0)
 ;;=BRAIN DISORDERS^6^3
 ;;^UTILITY(U,$J,358.4,18,0)
 ;;=CARDIOPULMONARY^7^3
 ;;^UTILITY(U,$J,358.4,19,0)
 ;;=COMPLICATION DUE TO^9^3
 ;;^UTILITY(U,$J,358.4,20,0)
 ;;=FRACTURES-LATE EFFECTS^11^3
 ;;^UTILITY(U,$J,358.4,21,0)
 ;;=MENTAL DISORDERS^12^3
 ;;^UTILITY(U,$J,358.4,22,0)
 ;;=MUSCULOSKELETAL/CONNECTIVE TISSUE^13^3
 ;;^UTILITY(U,$J,358.4,23,0)
 ;;=LATE EFFECTS OF INJURY^1^3
 ;;^UTILITY(U,$J,358.4,24,0)
 ;;=LATE EFFECTS OF CVA^2^3
 ;;^UTILITY(U,$J,358.4,25,0)
 ;;=PHYSICAL CHANGES^15^3
 ;;^UTILITY(U,$J,358.4,26,0)
 ;;=SPEECH AND LANGUAGE^18^3
 ;;^UTILITY(U,$J,358.4,27,0)
 ;;=AUDITORY^4^3
 ;;^UTILITY(U,$J,358.4,28,0)
 ;;=COGNITION^8^3
 ;;^UTILITY(U,$J,358.4,29,0)
 ;;=PSYCHIATRIC-PSYCHOSOC-EMOTIONAL^17^3
 ;;^UTILITY(U,$J,358.4,30,0)
 ;;=BACK DIAGNOSIS^5^3
 ;;^UTILITY(U,$J,358.4,31,0)
 ;;=EXTREMITY DIAGNOSIS^10^3
 ;;^UTILITY(U,$J,358.4,32,0)
 ;;=POST JOINT REPLACEMENT^16^3
 ;;^UTILITY(U,$J,358.4,33,0)
 ;;=OTHER^14^3
 ;;^UTILITY(U,$J,358.4,34,0)
 ;;=INITIAL EVAL FOR TBI^1^4
 ;;^UTILITY(U,$J,358.4,35,0)
 ;;=EST PATIENT^1^5
 ;;^UTILITY(U,$J,358.4,36,0)
 ;;=NEW PATIENT^2^5
 ;;^UTILITY(U,$J,358.4,37,0)
 ;;=CONSULTATION^3^5
 ;;^UTILITY(U,$J,358.4,38,0)
 ;;=V CODES ^19^6
 ;;^UTILITY(U,$J,358.4,39,0)
 ;;=AMPUTATION STATUS^3^6
 ;;^UTILITY(U,$J,358.4,40,0)
 ;;=BRAIN DISORDERS^6^6
 ;;^UTILITY(U,$J,358.4,41,0)
 ;;=CARDIOPULMONARY^7^6
 ;;^UTILITY(U,$J,358.4,42,0)
 ;;=COMPLICATION DUE TO^9^6
 ;;^UTILITY(U,$J,358.4,43,0)
 ;;=FRACTURES-LATE EFFECTS^11^6
 ;;^UTILITY(U,$J,358.4,44,0)
 ;;=MENTAL DISORDERS^12^6
 ;;^UTILITY(U,$J,358.4,45,0)
 ;;=MUSCULOSKELETAL/CONNECTIVE TISSUE^13^6
 ;;^UTILITY(U,$J,358.4,46,0)
 ;;=LATE EFFECTS OF INJURY^1^6
 ;;^UTILITY(U,$J,358.4,47,0)
 ;;=LATE EFFECTS OF CVA^2^6
 ;;^UTILITY(U,$J,358.4,48,0)
 ;;=PHYSICAL CHANGES^15^6
 ;;^UTILITY(U,$J,358.4,49,0)
 ;;=SPEECH AND LANGUAGE^18^6
 ;;^UTILITY(U,$J,358.4,50,0)
 ;;=AUDITORY^4^6
 ;;^UTILITY(U,$J,358.4,51,0)
 ;;=COGNITION^8^6
 ;;^UTILITY(U,$J,358.4,52,0)
 ;;=PSYCHIATRIC-PSYCHOSOC-EMOTIONAL^17^6
 ;;^UTILITY(U,$J,358.4,53,0)
 ;;=BACK DIAGNOSIS^5^6
 ;;^UTILITY(U,$J,358.4,54,0)
 ;;=EXTREMITY DIAGNOSIS^10^6
 ;;^UTILITY(U,$J,358.4,55,0)
 ;;=POST JOINT REPLACEMENT^16^6
 ;;^UTILITY(U,$J,358.4,56,0)
 ;;=OTHER^14^6
 ;;^UTILITY(U,$J,358.4,57,0)
 ;;=INITIAL EVAL FOR TBI^1^7
 ;;^UTILITY(U,$J,358.4,58,0)
 ;;=INJECTIONS/DRUGS^4^8
 ;;^UTILITY(U,$J,358.4,59,0)
 ;;=WOUND CARE^8^8
 ;;^UTILITY(U,$J,358.4,60,0)
 ;;=MD PROCEDURES^1^8
 ;;^UTILITY(U,$J,358.4,61,0)
 ;;=MUSCLE NERVE TESTS^5^8
 ;;^UTILITY(U,$J,358.4,62,0)
 ;;=TEAM CONFERENCE^7^8
 ;;^UTILITY(U,$J,358.4,63,0)
 ;;=ACUPUNCTURE^2^8
 ;;^UTILITY(U,$J,358.4,64,0)
 ;;=CHEMODENERVATION^3^8
 ;;^UTILITY(U,$J,358.4,65,0)
 ;;=OSTEOPATHIC MANIPULATION (OMT)^6^8
 ;;^UTILITY(U,$J,358.4,66,0)
 ;;=NEW PATIENT^2^9
 ;;^UTILITY(U,$J,358.4,67,0)
 ;;=ESTABLISHED PATIENT^1^9
 ;;^UTILITY(U,$J,358.4,68,0)
 ;;=CONSULTATIONS^3^9
 ;;^UTILITY(U,$J,358.4,69,0)
 ;;=GLOBAL FOLLOW UP^4^9
 ;;^UTILITY(U,$J,358.4,70,0)
 ;;=DIAGNOSIS^1^10
 ;;^UTILITY(U,$J,358.4,71,0)
 ;;=DEBRIDEMENT^2^11
 ;;^UTILITY(U,$J,358.4,72,0)
 ;;=DESTR-BENIGN/PREMALIGNANT^6^11
 ;;^UTILITY(U,$J,358.4,73,0)
 ;;=DEST MAL LESION-TRUNK,ARMS,LEGS^5^11
 ;;^UTILITY(U,$J,358.4,74,0)
 ;;=EXC-BEN LESION-TRUNK,ARM,LEG^9^11
 ;;^UTILITY(U,$J,358.4,75,0)
 ;;=EXC-MAL LESION-TRUNK,ARM,LEG^12^11
 ;;^UTILITY(U,$J,358.4,76,0)
 ;;=INCISION & DRAINAGE^13^11
 ;;^UTILITY(U,$J,358.4,77,0)
 ;;=MISCELLANEOUS^16^11
 ;;^UTILITY(U,$J,358.4,78,0)
 ;;=NAILS^18^11
 ;;^UTILITY(U,$J,358.4,79,0)
 ;;=SHAVING-EPIDERMAL-TRUNK,ARM,LEG^32^11
 ;;^UTILITY(U,$J,358.4,80,0)
 ;;=REPAIR-SIMPLE-SCALP,NK,TRUNK^29^11
 ;;^UTILITY(U,$J,358.4,81,0)
 ;;=REPAIR-INTERM-SCALP,TRUNK^27^11
 ;;^UTILITY(U,$J,358.4,82,0)
 ;;=DEST MAL LES-SCALP,NK,HAND,FEET,GENITALS^4^11
 ;;^UTILITY(U,$J,358.4,83,0)
 ;;=DEST MAL LESION-FACE,MUCOUS^3^11
 ;;^UTILITY(U,$J,358.4,84,0)
 ;;=EXC-BEN LESION-SCALP,HANDS,FT,GENITALS^8^11
 ;;^UTILITY(U,$J,358.4,85,0)
 ;;=EXC-BEN LESION-FACE,MUCOUS^7^11
 ;;^UTILITY(U,$J,358.4,86,0)
 ;;=EXC-MAL LESION-SCALP,NK,HAND,FT,GENITALS^11^11
 ;;^UTILITY(U,$J,358.4,87,0)
 ;;=EXC-MAL LESION-FACE,MUCOUS^10^11
 ;;^UTILITY(U,$J,358.4,88,0)
 ;;=SHAVING-EPIDERM-SCALP,NK,HAND,FT,GENITAL^31^11
 ;;^UTILITY(U,$J,358.4,89,0)
 ;;=SHAVING-EPIDERM-FACE,MUCOUS^30^11
 ;;^UTILITY(U,$J,358.4,90,0)
 ;;=REPAIR-SIMPLE-FACE,MUCOUS^28^11
 ;;^UTILITY(U,$J,358.4,91,0)
 ;;=REPAIR-INTERM-NK,HAND,FT,GENITALIA^26^11
 ;;^UTILITY(U,$J,358.4,92,0)
 ;;=REPAIR-INTERM-FACE,MUCOUS^25^11
 ;;^UTILITY(U,$J,358.4,93,0)
 ;;=WOUND HEALING^39^11
 ;;^UTILITY(U,$J,358.4,94,0)
 ;;=SKIN TEST^33^11
 ;;^UTILITY(U,$J,358.4,95,0)
 ;;=MICROBIOLOGY^15^11
 ;;^UTILITY(U,$J,358.4,96,0)
 ;;=MOHS CHEMOSURGERY^17^11
 ;;^UTILITY(U,$J,358.4,97,0)
 ;;=INJECTIONS^14^11
 ;;^UTILITY(U,$J,358.4,98,0)
 ;;=PEEL^19^11
 ;;^UTILITY(U,$J,358.4,99,0)
 ;;=PHOTOTHERAPY^20^11
 ;;^UTILITY(U,$J,358.4,100,0)
 ;;=REPAIR-COMPLEX-FACE^23^11
 ;;^UTILITY(U,$J,358.4,101,0)
 ;;=REPAIR-COMPLEX-NK/HAND/FT^24^11
 ;;^UTILITY(U,$J,358.4,102,0)
 ;;=REPAIR-COMPLEX-TRUNK^21^11
 ;;^UTILITY(U,$J,358.4,103,0)
 ;;=TISSUE REARRANGEMENT-FACE/NECK/HAND/FOOT^36^11
 ;;^UTILITY(U,$J,358.4,104,0)
 ;;=TISSUE REARRANGEMENT-SCALP/ARMS/LEGS^35^11
 ;;^UTILITY(U,$J,358.4,105,0)
 ;;=TISSUE REARRANGEMENT-TRUNK^34^11
 ;;^UTILITY(U,$J,358.4,106,0)
 ;;=REPAIR-COMPLEX-SCALP^22^11
 ;;^UTILITY(U,$J,358.4,107,0)
 ;;=TISSUE REARRANGEMENT-EYELID/NOSE/EAR/LIP^37^11
 ;;^UTILITY(U,$J,358.4,108,0)
 ;;=BIOPSY^1^11
 ;;^UTILITY(U,$J,358.4,109,0)
 ;;=TISSUE REARRANGEMENT-ANY AREA^38^11
 ;;^UTILITY(U,$J,358.4,110,0)
 ;;=NEW PATIENT^2^12
 ;;^UTILITY(U,$J,358.4,111,0)
 ;;=ESTABLISHED PATIENT^1^12
 ;;^UTILITY(U,$J,358.4,112,0)
 ;;=CONSULTATION^3^12
 ;;^UTILITY(U,$J,358.4,113,0)
 ;;=ALPHA ORDER (A)^2^13
 ;;^UTILITY(U,$J,358.4,114,0)
 ;;=ALPHA ORDER (B)^3^13
 ;;^UTILITY(U,$J,358.4,115,0)
 ;;=ALPHA ORDER (C)^4^13
 ;;^UTILITY(U,$J,358.4,116,0)
 ;;=ALPHA ORDER (D)^5^13
 ;;^UTILITY(U,$J,358.4,117,0)
 ;;=ALPHA ORDER (E)^6^13
 ;;^UTILITY(U,$J,358.4,118,0)
 ;;=ALPHA ORDER (F)^7^13
 ;;^UTILITY(U,$J,358.4,119,0)
 ;;=ALPHA ORDER (G)^8^13
 ;;^UTILITY(U,$J,358.4,120,0)
 ;;=ALPHA ORDER (H)^9^13
 ;;^UTILITY(U,$J,358.4,121,0)
 ;;=ALPHA ORDER (I)^10^13
 ;;^UTILITY(U,$J,358.4,122,0)
 ;;=ALPHA ORDER (K)^11^13
 ;;^UTILITY(U,$J,358.4,123,0)
 ;;=ALPHA ORDER (L)^12^13
 ;;^UTILITY(U,$J,358.4,124,0)
 ;;=ALPHA ORDER (M)^13^13
 ;;^UTILITY(U,$J,358.4,125,0)
 ;;=ALPHA ORDER (N)^14^13
 ;;^UTILITY(U,$J,358.4,126,0)
 ;;=ALPHA ORDER (O)^15^13
 ;;^UTILITY(U,$J,358.4,127,0)
 ;;=ALPHA ORDER (P)^16^13
 ;;^UTILITY(U,$J,358.4,128,0)
 ;;=ALPHA ORDER (R)^17^13
 ;;^UTILITY(U,$J,358.4,129,0)
 ;;=ALPHA ORDER (S)^18^13
 ;;^UTILITY(U,$J,358.4,130,0)
 ;;=ALPHA ORDER (T)^19^13
 ;;^UTILITY(U,$J,358.4,131,0)
 ;;=ALPHA ORDER (U)^20^13
 ;;^UTILITY(U,$J,358.4,132,0)
 ;;=ALPHA ORDER (V)^21^13
 ;;^UTILITY(U,$J,358.4,133,0)
 ;;=ALPHA ORDER (X)^22^13
 ;;^UTILITY(U,$J,358.4,134,0)
 ;;=V CODES^23^13
 ;;^UTILITY(U,$J,358.4,135,0)
 ;;=INCISION & DRAINAGE^10^14
 ;;^UTILITY(U,$J,358.4,136,0)
 ;;=DEBRIDEMENT^5^14
 ;;^UTILITY(U,$J,358.4,137,0)
 ;;=SHAVING EPIDERMAL/DERMAL LESIONS^24^14
 ;;^UTILITY(U,$J,358.4,138,0)
 ;;=NAILS^14^14
 ;;^UTILITY(U,$J,358.4,139,0)
 ;;=PARING OR CUTTING^19^14
 ;;^UTILITY(U,$J,358.4,140,0)
 ;;=DESTRUCTION-BENIGN OR PREMALIGANT^6^14
 ;;^UTILITY(U,$J,358.4,141,0)
 ;;=EXCISION-BENIGN LESION (EXCEPT SKIN TAG)^7^14
 ;;^UTILITY(U,$J,358.4,142,0)
 ;;=EXCISION-MALIGNANT LESIONS^9^14
 ;;^UTILITY(U,$J,358.4,143,0)
 ;;=REPAIR/CLOSURE^23^14
 ;;^UTILITY(U,$J,358.4,144,0)
 ;;=BURNS^3^14
 ;;^UTILITY(U,$J,358.4,145,0)
 ;;=OTHER SKIN PROCEDURES^18^14
 ;;^UTILITY(U,$J,358.4,146,0)
 ;;=INJECTION ADMIN^12^14
 ;;^UTILITY(U,$J,358.4,147,0)
 ;;=INJECTION SUBSTANCE^13^14
 ;;^UTILITY(U,$J,358.4,148,0)
 ;;=REPAIR, REVISE and/or RECONSTRUCT^22^14
 ;;^UTILITY(U,$J,358.4,149,0)
 ;;=INCISION-FOOT/TOES^11^14
 ;;^UTILITY(U,$J,358.4,150,0)
 ;;=EXCISION-FOOT/TOES^8^14
 ;;^UTILITY(U,$J,358.4,151,0)
 ;;=OTHER PROCEDURES^17^14
 ;;^UTILITY(U,$J,358.4,152,0)
 ;;=OPEN OR CLOSED TREATMENT OF FRACTURES^15^14
 ;;^UTILITY(U,$J,358.4,153,0)
 ;;=ARTHRODESIS^2^14
 ;;^UTILITY(U,$J,358.4,154,0)
 ;;=CASTS/SPLINTS/STRAPPING APPLICATION^4^14
 ;;^UTILITY(U,$J,358.4,155,0)
 ;;=REMOVAL/REPAIR OF CASTS^21^14
 ;;^UTILITY(U,$J,358.4,156,0)
 ;;=ORTHOTICS^16^14
 ;;^UTILITY(U,$J,358.4,157,0)
 ;;=SUPPLIES^25^14
 ;;^UTILITY(U,$J,358.4,158,0)
 ;;=REMOVAL^20^14
 ;;^UTILITY(U,$J,358.4,159,0)
 ;;=AMPUTATION^1^14
 ;;^UTILITY(U,$J,358.4,160,0)
 ;;=GRAFT^10^14
 ;;^UTILITY(U,$J,358.4,161,0)
 ;;=NAILS^2^15
 ;;^UTILITY(U,$J,358.4,162,0)
 ;;=OTHER ORTHOTICS^3^15
 ;;^UTILITY(U,$J,358.4,163,0)
 ;;=IMMUNIZATIONS^1^15
 ;;^UTILITY(U,$J,358.4,164,0)
 ;;=ESTABLISHED PATIENT^1^16
 ;;^UTILITY(U,$J,358.4,165,0)
 ;;=ALPHA ORDER (A)^2^17
 ;;^UTILITY(U,$J,358.4,166,0)
 ;;=ALPHA ORDER (B)^3^17
 ;;^UTILITY(U,$J,358.4,167,0)
 ;;=ALPHA ORDER (C)^4^17
 ;;^UTILITY(U,$J,358.4,168,0)
 ;;=ALPHA ORDER (D)^5^17
